2Chen JK, Wang SY, Hou YH. Primary dapsone resistance in China [J]. Lepr Rev, 1989,60(4) :263-266.
3Browne SG, Hogerzeil LM. "B 663" in the treatment of leprosy. Preliminary report of a pilot trial [J]. Lepr Rev, 1962, 33:6-10.
4Levy L, Shepard CC, Fasal P. The bactericidal effect of rifampicin on M.leprae in man: a single doses of 600, 900and 1200 mg; and b daily doses of 300 mg [J ]. Int J Lepr Other Mycobact Dis, 1976,44(1-2) : 183-187.
6Ji B. Treatment of leprosy [ M ]. 1998 : 398-424.
7Ebenezer G J, Norman G, Joseph GA. Drug resistant Mycobacterium leprae-results of mouse footpad studies from a laboratory in south India [J]. Indian J Lepr, 2002,74(4): 301-312.
8Williams DL, Gillis TP. Molecular detection of drug resistance in Mycobacterium leprae [J]. Lepr Rev, 2004,75(2) : 118-130.
9Gelber RH. Successful treatment of a lepromatous patient with clarithromycin [J]. Int J Lepr Other Mycobact Dis, 1995,63 (1):113-115.
10Ji B, Sow S, Perani E, et al. Bactericidal activity of a singledose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients [J]. Antimicrob Agents Chemother, 1998,42(5):1115-1120.
